Are liquid biopsy tests a game changer in the fight against cancer?

Cancer is a leading cause of morbidity and mortality worldwide, with many deaths linked to cancer types that lack screening options. Multi-cancer early detection tests can be a game changer in this space, but Swiss Re's Medical Officer and cancer expert Dr. Tobias Schiergens explains why this form of liquid biopsy is not ready yet for prime-time.
Learn more: www.swissre.com/institute/res...
Swiss Re
The Swiss Re Group is one of the world’s leading providers of reinsurance, insurance and other forms of insurance-based risk transfer, working to make the world more resilient. It anticipates and manages risk - from natural catastrophes to climate change, from ageing populations to cyber crime. The aim of the Swiss Re Group is to enable society to thrive and progress, creating new opportunities and solutions for its clients. Headquartered in Zurich, Switzerland, where it was founded in 1863, the Swiss Re Group operates through a network of around 80 offices globally.
#cancerscreening #cancerdetection #biopsy #cancer